BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 53067)

  • 1. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
    Singer A; Shelton J; Hill S; Potter C
    Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
    Flavell DJ; Singer A; Potter CW
    Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
    Flavell DJ; Potter CW
    Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoantigens ABO in cervical neoplasia.
    Stafl A; Mattingly RF
    Gynecol Oncol; 1972 Nov; 1(1):26-35. PubMed ID: 4669441
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.
    Flavell DJ; Goepel J; Potter CW; Carr I
    Br J Cancer; 1978 May; 37(5):818-26. PubMed ID: 77674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinitrochlorobenzene reactivity of women with cancer of the ovary, cervix and corpus uteri.
    Khoo SK; Mackay E; Daunter B
    Int J Gynaecol Obstet; 1978 Jul-1979 Aug; 17(1):58-62. PubMed ID: 39839
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of dysplasia and corcinoma in situ of the cervix uteri].
    Pieroni G; Bonardi L; Ottaviano M; Marchionni M
    Minerva Ginecol; 1975 May; 27(5):393-403. PubMed ID: 1134689
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dysplasia and carcinoma in situ of the uterine portio. Clinical, histopathological and histochemical findings].
    Bertaglia A; De Gaetani CF; Trentini GP
    Arch De Vecchi Anat Patol; 1974 Aug; 60(1):29-41. PubMed ID: 4470381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dysplasia and carcinoma in situ of the cervix uteri].
    Vooys GP
    Ned Tijdschr Geneeskd; 1975 Mar; 119(9):358-66. PubMed ID: 1134600
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphology and histogenesis of dysplasias of the cervix uteri].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1985; 47(11):32-7. PubMed ID: 4091694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Papilloma virus-induced changes in the uterine cervix. Histo- and cytologic and epidemiologic findings].
    Barten G; Rohde E; Beust M
    Zentralbl Gynakol; 1985; 107(10):634-9. PubMed ID: 2990121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management and natural history of severe dysplasia and carcinoma in situ of the uterine cervix.
    Gad C
    Br J Obstet Gynaecol; 1976 Jul; 83(7):554-9. PubMed ID: 952784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity in carcinoma of the uterine cervix.
    Lambert B; Boushira M; Pelletier M; Montplaisir S
    Gynecol Oncol; 1984 Mar; 17(3):394-5. PubMed ID: 6608476
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of cryosurgery for dysplasia and carcinoma in situ of the uterine cervix.
    Elmfors B; Stormby N
    Br J Obstet Gynaecol; 1979 Dec; 86(12):917-21. PubMed ID: 526449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of epithelial-specific antigen for cytological diagnosis of glandular lesions in the uterine cervix.
    Matsui N; Kajiwara H; Morishita A; Iida T; Nakazawa K; Miyazawa M; Mikami M; Ogawa T; Nakamura N; Sato S
    Pathol Int; 2016 May; 66(5):305-8. PubMed ID: 26792568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.